Correlation between Elevated Nerve Growth Factor mRNA Expression with Pain Intensity or Disease Severity in Endometriosis

This study examined whether nerve growth factor (NGF) mRNA expression is associated with pain intensity and disease severity in 30 women with endometriosis undergoing surgery, measuring NGF mRNA in both blood plasma and ectopic endometriosis tissue. Pain history was collected retrospectively and disease stage was assessed intraoperatively, with NGF mRNA quantified using the Livak relative expression method and compared between plasma and lesions. The authors found no significant correlation between NGF mRNA expression levels and either pain levels or endometriosis severity in plasma or lesion tissue, while NGF expression differed significantly between blood and lesions and was higher in ectopic tissue (with the plasma–lesion comparison reported as significant). This paper does not explicitly discuss limitations beyond noting that NGF expression may be influenced by many factors and may not always track severity, which constrains interpretation of its lack of association. This paper is centrally about endometriosis — it specifically tests whether NGF mRNA relates to pain intensity and disease severity in endometriosis patients.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works